High throughput sequencing analysis of RNA libraries reveals the influences of initial library and PCR methods on SELEX efficiency.

Applications of High-Throughput Sequencing for In Vitro Selection and Characterization of Aptamers. Pharmaceuticals (Basel) (2016) 0.80

AptaTRACE Elucidates RNA Sequence-Structure Motifs from Selection Trends in HT-SELEX Experiments. Cell Syst (2016) 0.76

Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science (1990) 35.96

In vitro selection of RNA molecules that bind specific ligands. Nature (1990) 30.19

Bias and artifacts in multitemplate polymerase chain reactions (PCR). J Biosci Bioeng (2003) 4.70

Aptamer-based multiplexed proteomic technology for biomarker discovery. PLoS One (2010) 3.64

Overexpression of TAR sequences renders cells resistant to human immunodeficiency virus replication. Cell (1990) 3.36

Aptamers as therapeutic and diagnostic agents. J Biotechnol (2000) 2.89

Rapid identification of cell-specific, internalizing RNA aptamers with bioinformatics analyses of a cell-based aptamer selection. PLoS One (2012) 1.60

Therapeutic RNA aptamers in clinical trials. Eur J Pharm Sci (2012) 1.56

Cell-specific RNA aptamer against human CCR5 specifically targets HIV-1 susceptible cells and inhibits HIV-1 infectivity. Chem Biol (2015) 1.53

Delivery of chemo-sensitizing siRNAs to HER2+-breast cancer cells using RNA aptamers. Nucleic Acids Res (2012) 1.47

Single-molecule PCR using water-in-oil emulsion. J Biotechnol (2003) 1.34

Cell-type-specific, Aptamer-functionalized Agents for Targeted Disease Therapy. Mol Ther Nucleic Acids (2014) 1.32

Monitoring genomic sequences during SELEX using high-throughput sequencing: neutral SELEX. PLoS One (2010) 1.28

Nucleotide bias observed with a short SELEX RNA aptamer library. Nucleic Acid Ther (2011) 1.15

A streamlined protocol for emulsion polymerase chain reaction and subsequent purification. Anal Biochem (2010) 1.15

Current progress of RNA aptamer-based therapeutics. Front Genet (2012) 1.12

Selection of aptamers by systematic evolution of ligands by exponential enrichment: addressing the polymerase chain reaction issue. Anal Chim Acta (2005) 1.12

Large scale analysis of the mutational landscape in HT-SELEX improves aptamer discovery. Nucleic Acids Res (2015) 1.11

Current progress on aptamer-targeted oligonucleotide therapeutics. Ther Deliv (2013) 1.09

A Highlight of Recent Advances in Aptamer Technology and Its Application. Molecules (2015) 0.99

Cell-SELEX Technology. Biores Open Access (2012) 0.98

Replacing antibodies with aptamers in lateral flow immunoassay. Biosens Bioelectron (2015) 0.97

Emulsion PCR: a high efficient way of PCR amplification of random DNA libraries in aptamer selection. PLoS One (2011) 0.91

Aptamers and SELEX in Chemistry & Biology. Chem Biol (2014) 0.91

Identifying high-affinity aptamer ligands with defined cross-reactivity using high-throughput guided systematic evolution of ligands by exponential enrichment. Nucleic Acids Res (2015) 0.85

Emulsion PCR significantly improves nonequilibrium capillary electrophoresis of equilibrium mixtures-based aptamer selection: allowing for efficient and rapid selection of aptamer to unmodified ABH2 protein. Anal Chem (2014) 0.84

Aptamers as theranostic agents: modifications, serum stability and functionalisation. Sensors (Basel) (2013) 0.84

Aptamer-siRNA chimeras for HIV. Adv Exp Med Biol (2015) 0.83

Hi-Fi SELEX: A High-Fidelity Digital-PCR Based Therapeutic Aptamer Discovery Platform. Biotechnol Bioeng (2015) 0.83

Fluorescence imaging using synthetic GFP chromophores. Curr Opin Chem Biol (2015) 0.83

Design, synthesis, and amplification of DNA pools for in vitro selection. Curr Protoc Mol Biol (2009) 0.82

Trends in the Design and Development of Specific Aptamers Against Peptides and Proteins. Protein J (2016) 0.81

Applications of aptamers in targeted imaging: state of the art. Curr Top Med Chem (2015) 0.79

Nanoscaled aptasensors for multi-analyte sensing. Bioimpacts (2014) 0.79

Oligonucleotide aptamers: A next-generation technology for the capture and detection of circulating tumor cells. Methods (2015) 0.78

Status and Prospects of Aptamers as Drug Components. BioDrugs (2015) 0.76

Identification and Characterization of an eIF4e DNA Aptamer That Inhibits Proliferation With High Throughput Sequencing. Mol Ther Nucleic Acids (2014) 0.76

LGIT In Vitro Latency Model in Primary and T Cell Lines to Test HIV-1 Reactivation Compounds. Methods Mol Biol (2016) 0.75